Previous Close | 8.56 |
Open | 8.54 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 8.27 - 8.57 |
52 Week Range | 7.33 - 23.22 |
Volume | |
Avg. Volume | 962,435 |
Market Cap | 1.063B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jun 16, 2016 |
1y Target Est | N/A |
On October 15, 2024, Two Seas Capital LP (Trades, Portfolio) made a significant addition to its investment portfolio by acquiring 400,001 shares of Indivior PLC (NASDAQ:INDV), a specialty drug manufacturing company. This transaction has increased the firm's total holdings in Indivior to 13,030,027 shares, marking a substantial influence on its investment strategy. Two Seas Capital LP (Trades, Portfolio), based at 1 Read Court, New York, NY 10580, is a prominent investment firm known for its strategic positions in the healthcare and utilities sectors.
Craig-Hallum lowered the firm’s price target on Indivior to $16 from $20 and keeps a Buy rating on the shares. While Q3 pre-released results were relatively in-line and ahead of expectations on the overall top-line, FY24 guidance was revised lower in what the firm calls “a disappointing update.” The company lowering FY24 net revenue guidance was “entirely driven by worsening fundamentals for Sublocade,” notes the analyst, who calls Sublocade “the chief value driver for Indivior.” There is hope f
Indivior PLC (INDV) outlines strategic initiatives to bolster SUBLOCADE's market position amidst increased competition and evolving market dynamics.